Variation by race in factors contributing to heart failure hospitalizations.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 15704060)

Published in J Card Fail on February 01, 2005

Authors

Hardeep Singh1, Howard S Gordon, Anita Deswal

Author Affiliations

1: Medical Care Line, VA Medical Center & Baylor College of Medicine, Houston, Texas, USA.

Articles by these authors

Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99

Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA (2013) 4.85

Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? J Gen Intern Med (2003) 4.11

Patient participation in medical consultations: why some patients are more involved than others. Med Care (2005) 3.68

Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail (2012) 2.88

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol (2012) 2.56

Missed opportunities for interval empathy in lung cancer communication. Arch Intern Med (2008) 2.12

Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol (2009) 2.08

Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail (2010) 1.82

Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest (2003) 1.73

Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J (2007) 1.52

Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf (2011) 1.50

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail (2012) 1.46

The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol (2007) 1.45

Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail (2012) 1.43

Biomarkers of inflammation in heart failure. Heart Fail Rev (2010) 1.40

Time to sign: The relationship between health literacy and signature time. Patient Educ Couns (2012) 1.39

Effect of definition of mortality on hospital profiles. Med Care (2002) 1.36

The effect of patient race on total joint replacement recommendations and utilization in the orthopedic setting. J Gen Intern Med (2010) 1.35

Companion participation in cancer consultations. Psychooncology (2008) 1.26

Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J (2012) 1.24

Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol (2008) 1.23

Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg (2011) 1.17

Mortality after cardiac bypass surgery: prediction from administrative versus clinical data. Med Care (2005) 1.10

Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J (2005) 1.10

The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg (2008) 1.07

Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail (2015) 1.07

'A little bitty spot and I'm a big man': patients' perspectives on refusing diagnosis or treatment for lung cancer. Psychooncology (2005) 1.06

Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem (2013) 1.06

The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol (2010) 1.04

A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med (2010) 1.03

Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail (2002) 1.01

Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail (2013) 1.00

Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose. N Engl J Med (2003) 1.00

Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States. Cancer (2011) 0.96

Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail (2008) 0.93

Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci (2003) 0.93

"There's no cure for this condition": how physicians discuss advance care planning in heart failure. Patient Educ Couns (2013) 0.92

Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry (2009) 0.92

Factors influencing perceptions of breast cancer genetic counseling among women in an urban health care system. J Genet Couns (2007) 0.92

Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol (2009) 0.89

The clinical context and patient participation in post-diagnostic consultations. Patient Educ Couns (2006) 0.88

Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry (2010) 0.88

Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol (2012) 0.87

Depression and anxiety in ambulatory patients with heart failure. Psychosomatics (2009) 0.87

Orthopedic communication about osteoarthritis treatment: Does patient race matter? Arthritis Care Res (Hoboken) (2011) 0.86

Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J (2011) 0.86

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag (2010) 0.85

Missed opportunities for advance care planning communication during outpatient clinic visits. J Gen Intern Med (2011) 0.83

New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail (2011) 0.83

Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol (2013) 0.83

Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med (2010) 0.83

A quasi-experimental test of an intervention to increase the use of thiazide-based treatment regimens for people with hypertension. Implement Sci (2007) 0.83

Mortality after hospitalization for heart failure in blacks compared to whites. Am J Cardiol (2010) 0.83

Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol (2004) 0.82

New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail (2011) 0.82

Obesity, leptin, and incident heart failure. J Am Coll Cardiol (2011) 0.82

Efficiency of colorectal cancer care among veterans: analysis of treatment wait times at Veterans Affairs Medical Centers. J Oncol Pract (2013) 0.81

Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther (2013) 0.80

A brief self-affirmation study to improve the experience of minority patients. Appl Psychol Health Well Being (2013) 0.80

The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail (2008) 0.80

Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction. J Thorac Cardiovasc Surg (2008) 0.80

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation (2016) 0.80

Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation (2016) 0.78

New therapeutics for chronic heart failure. Annu Rev Med (2002) 0.78

What we've got here is a failure to communicate. J Gen Intern Med (2011) 0.77

Anti-angiotensin therapy: new perspectives. Cardiol Clin (2007) 0.77

Decreasing body temperature predicts early rehospitalization in congestive heart failure. J Card Fail (2008) 0.77

Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail (2012) 0.77

Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin (2008) 0.76

Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol (2009) 0.76

Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”. Circ Heart Fail (2015) 0.75

Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality. Ann Intern Med (2016) 0.75

Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. J Obes Weight Loss Ther (2012) 0.75

Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction. Evid Based Med (2013) 0.75

Advance care planning safeguards. J Gen Intern Med (2012) 0.75

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol (2010) 0.75

African American Veterans Storytelling: A Multisite Randomized Trial to Improve Hypertension. Med Care (2017) 0.75

Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure. Heart Fail Monit (2002) 0.75

Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol (2008) 0.75

Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol (2011) 0.75

The fragility of cardiovascular clinical trial results. J Card Fail (2002) 0.75

Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy. Heart Fail Clin (2005) 0.75

Perils of the random experiment. Am J Ther (2003) 0.75

Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular disease. J Card Fail (2005) 0.75

ACP Journal Club. Review: in systolic heart failure, low-sodium diets increase mortality compared with normal-sodium diets. Ann Intern Med (2013) 0.75